Cyclerion Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
/ 
Frequently asked questions
To buy Cyclerion Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cyclerion Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cyclerion Therapeutics Inc. is CYCN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cyclerion Therapeutics Inc. has its primary listing on NASDAQ. You can trade Cyclerion Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cyclerion Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Cyclerion Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Cyclerion Therapeutics Inc..